製薬産業における産学共同研究の実証分析:産学共同研究は企業にとって良い選択か  [in Japanese] An Analysis of Collaborative Research Between Academia and Industry::Is it a Good Choice for Industries to Conduct Collaborative Researches with Universities?  [in Japanese]

Access this Article

Search this Article

Author(s)

Abstract

<p> 本研究は,製薬産業における産学共同研究成果の評価を目的として,特許の技術品質(被引用特許数)および開発プロセス品質(出願国数,特許登録)に対する発明形態・出願形態別の効果を回帰分析により検討した.その結果,技術品質は開発プロセス品質に対して強い正の効果を有している事,産学共同発明は技術品質に対して負の効果を有する事が明らかになった.一方で,対象とする疾患領域・技術タイプを選ぶことによって技術品質の高い成果を生み出す可能性がある事も明らかとなった.</p>

<p>The aim of this study is to investigate a performance of collaborative researches between academia and the pharmaceutical industry. We conduct an empirical study with a dataset of patent applications and a directory service of academic researchers. The study measures the qualities of technology development (TD) and product development (PD), by using such multiple indexes as number of citations, patent grants, and foreign applications.<br>The empirical results suggest that TD quality has a positive effect on PD quality, while industry-university (IU) inventions have a lower TD quality than the industry-alone inventions. In certain disease areas, however, IU inventions receive more citations than the industry-alone inventions, meaning that IU inventions enjoy better TD quality. These findings also indicate that we can expect better achievement from collaborative researches by focusing on appropriate disease areas.</p>

Journal

  • Organizational Science

    Organizational Science 52(1), 18-31, 2018

    The Academic Association for Organizational Science

Codes

  • NII Article ID (NAID)
    130007580503
  • NII NACSIS-CAT ID (NCID)
    AN00135007
  • Text Lang
    JPN
  • ISSN
    0286-9713
  • NDL Article ID
    029309917
  • NDL Call No.
    Z6-525
  • Data Source
    NDL  J-STAGE 
Page Top